Another two diagnostic markers for both PTC and FTC are HBME-1 and trophoblast cell surface antigen-2 (Trop-2), which have recently emerged as a powerful combination for differentiating between malignant and benign lesions [43,44]. The gene discussed is TACSTD2; the disease is thyroid cancer, nonmedullary, 2.